Castle Biosciences, Inc.

From Castle Biosciences's results release of 5 Kasım 2026; its quarterly report has since been filed.

• Revenue

  Actual

  $102,9M

  +%24 y/y ↑
  -%0,6 q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  -$0,13

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  -$2,7M

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.